CRL — Charles River Laboratories International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
$12.43bn
Enterprise Value
$14.87bn
Revenue
$4.13bn

Annual balance sheet for Charles River Laboratories International, fiscal year end - December 30th, USD millions except per share, conversion factor applied.

	2019 December 28th	2020 December 26th	2021 December 25th	2022 December 31st	2023 December 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	239	229	242	235	277
Net Total Accounts Receivable
Net Total Receivables	514	618	650	752	780
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,021	1,201	1,274	1,439	1,609
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,184	1,303	1,584	1,857	2,034
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4,693	5,491	7,024	7,603	8,195
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	710	840	1,033	1,092	1,055
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,058	3,376	4,489	4,626	4,598
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,635	2,115	2,535	2,976	3,597
Total Liabilities & Shareholders' Equity	4,693	5,491	7,024	7,603	8,195
Total Common Shares Outstanding